Stock Earnings

Question 1

Takeda Pharmaceutical Company Limited 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Takeda Pharmaceutical Company Limited 的总资产为 $14,248,344，净利润为 $107,928

Question 2

TAK 的关键财务比率是什么？

Accepted Answer

Takeda Pharmaceutical Company Limited 的流动比率是 1.94，净利 margin 为 2.35，每股销售为 $2,901.78。

Question 3

Takeda Pharmaceutical Company Limited 的收入按细分市场或地理位置如何划分？

Accepted Answer

Takeda Pharmaceutical Company Limited 最大收入来源是 Gastroenterology Revenue (Pre-FY2023 Reporting)，在最近的收益报告中收入为 1,216,207,000,000。就地区而言， Japan 是 Takeda Pharmaceutical Company Limited 的主要市场，收入为 418,462,000,000。

Question 4

Takeda Pharmaceutical Company Limited 是否盈利？

Accepted Answer

是的，根据最新的财务报表，Takeda Pharmaceutical Company Limited 的净利润为 $107,928

Question 5

Takeda Pharmaceutical Company Limited 有负债吗？

Accepted Answer

是的，Takeda Pharmaceutical Company Limited 的负债为 7,313,260

Question 6

Takeda Pharmaceutical Company Limited 的流通股有多少？

Accepted Answer

Takeda Pharmaceutical Company Limited 的总流通股为 1,573.64

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
营收	4,464,578	4,581,551	4,263,762	4,027,478	3,569,006	3,197,812
营收同比增长 (YoY)	-3%	7%	6%	13%	12%	-3%
营收成本	1,547,962	1,580,217	1,426,678	1,244,072	1,106,846	994,308
毛利	2,916,616	3,001,334	2,837,084	2,783,406	2,462,160	2,203,504
销售、一般及管理费用	1,088,085	1,104,766	1,053,819	997,309	886,361	875,663
研发	696,611	730,227	729,924	633,325	526,087	455,833
营业费用	2,436,102	2,446,630	2,406,297	2,232,511	1,916,672	1,867,782
其他非经营性收入 (费用)	--	0	1	--	1	--
税前利润	205,369	175,084	52,791	375,090	302,571	366,235
所得税费用	92,184	66,941	-91,406	58,052	72,405	-9,936
净利润	112,926	107,928	144,067	317,017	230,059	376,005
净利润增长	-46%	-25%	-55%	38%	-39%	750%
稀释后流通股数	1,578.74	1,578.87	1,564.45	1,569.87	1,577.16	1,573.53
股份同比变动 (YoY)	0%	1%	0%	0%	0%	0%
每股收益 (摊薄)	71.52	68.35	92.08	201.93	145.86	238.95
每股收益增长率	-46%	-26%	-54%	38%	-39%	746%
自由现金流	748,694	709,341	235,614	343,467	937,068	774,463
每股自由现金流	--	--	--	--	--	--
毛利率	65.32%	65.5%	66.53%	69.11%	68.98%	68.9%
营业利润率	10.76%	12.1%	10.1%	13.67%	15.28%	10.49%
净利率	2.52%	2.35%	3.37%	7.87%	6.44%	11.75%
自由现金流利润率	16.76%	15.48%	5.52%	8.52%	26.25%	24.21%
EBITDA	1,029,232	1,102,890	952,312	1,093,338	1,018,403	757,586
EBITDA 利润率	23.05%	24.07%	22.33%	27.14%	28.53%	23.69%
EBITDA 中的折旧与摊销	548,718	548,186	521,525	542,443	472,915	421,864
EBIT	480,514	554,704	430,787	550,895	545,488	335,722
EBIT 利润率	10.76%	12.1%	10.1%	13.67%	15.28%	10.49%
有效税率	44.88%	38.23%	-173.14%	15.47%	23.92%	-2.71%

Takeda Pharmaceutical Company Limited (TAK) 财务

TAK 股价走势图

关键数据

前收盘价

开盘价

当日区间

52周范围

交易量

平均成交量

股息收益率

每股收益（TTM）

市值

什么是 Takeda Pharmaceutical Company L？

TAK 收入

Follow-Up Questions